View : 216 Download: 0

Extended versus peripancreatic lymph node dissection for the treatment of left-sided pancreatic cancer

Title
Extended versus peripancreatic lymph node dissection for the treatment of left-sided pancreatic cancer
Authors
Lee, HuisongHeo, Jin SeokChoi, Seong HoChoi, Dong Wook
Ewha Authors
이희성
SCOPUS Author ID
이희성scopus
Issue Date
2017
Journal Title
ANNALS OF SURGICAL TREATMENT AND RESEARCH
ISSN
2288-6575JCR Link

2288-6796JCR Link
Citation
ANNALS OF SURGICAL TREATMENT AND RESEARCH vol. 92, no. 6, pp. 411 - 418
Keywords
PancreasNeoplasmsLymph node excisionSurvival
Publisher
KOREAN SURGICAL SOCIETY
Indexed
SCIE; SCOPUS; KCI WOS scopus
Document Type
Article
Abstract
Purpose: The pathways of lymphatic metastases differ according to the tumor location in pancreatic cancer patients. However, it is unclear whether extended lymph node dissection (LND) is essential for all left-sided pancreatic cancer. The aim of this study is to evaluate the survival outcomes according to the extent of LND and tumor location in patients with left-sided pancreatic cancer. Methods: January 2005 to December 2013, we retrospectively identified 107 patients who underwent curative intent surgery for left-sided pancreatic cancer. The left-sided pancreatic cancer was defined as a tumor located in pancreatic body or tail. The extent of LND was divided into 2 groups: extended LND and peripancreatic LND. The extended LND group included celiac and superior mesenteric LNs. Results: We included 107 patients with left-sided pancreatic cancer; 59 patients with pancreatic body cancer and 48 patients with pancreatic tail cancer. The median follow-up period was 17 months (range, 3-110 months). Fifty patients with pancreatic body cancer and 30 patients with pancreatic tail cancer underwent extended LND. In patients with pancreatic body cancer, extended LND was associated with improved disease-free survival (DFS) (P = 0.010) and overall survival (P = 0.014). However, extended LND was not associated with DFS in patients with pancreatic tail cancer. Conclusion: Extended LND could improve survival in patients with pancreatic body cancer. However, extended LND had no survival benefit for the treatment-of pancreatic tail cancer.
Show the fulltext
DOI
10.4174/astr.2017.92.6.411
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE